Heartworm-positive dogs recover without complications from surgical sterilization using cardiovascular sparing anesthesia protocol

Interventional Heartworm Extraction in Two Dogs: The Clinical Application of Impedance Cardiography

Heartworm (HW) disease, caused by Dirofilaria immitis, is a life-threatening ailment in dogs. HW disrupts blood flow and decreases cardiac output (CO). The accurate monitoring of CO during HW extraction is pivotal for patient survival and overall health.

OBJECTIVE

This study aimed to assess the efficacy of using impedance cardiography (ICG) as a non-invasive approach for monitoring CO during interventional HW extraction.

METHODS

Two cases of HW infections were treated via surgical extraction. The CO and mean arterial pressure (MAP) were monitored using the ICG technique during the anesthesia stabilization, extraction process, and post-extraction phases.

RESULTS

In Case 1, the CO increased by 115% post-procedure, and in Case 2, the CO increased by 116%. In contrast, the MAP varied between the two cases. The ICG method provided real-time CO data without major disruptions during the extraction surgery.

CONCLUSION

The ICG technique for CO monitoring during interventional HW extractions is effective.

Anesthesia for the dog with heartworm disease: a brief, practical review

Dogs with heartworm disease may present for procedures that require anesthesia. This article is a brief, practical review of anesthetic techniques for dogs with heartworm. Dogs with heartworm, such as in a shelter that undergo spay and neuter procedures, may be safely anesthetized prior to heartworm treatment. The dog presenting with caval syndrome may require emergent anesthesia for extraction of the heartworms; anesthetic drugs and potential adverse effects are discussed. The anesthetic agents that have been used are discussed.

Treatment and management of Salmonella prostatitis in a heartworm-positive intact male dog: a case report

Background

Salmonella spp. represent a significant zoonotic concern to pregnant owners as infection can cause septic abortions and post-partum illness. Enteric salmonellosis is well documented in canines however urinary salmonellosis is rarely described and Salmonella prostatitis has never been described in dogs.

Case presentation

This case report describes the diagnosis and management of a five-year-old, intact male Labrador Retriever mix dog that was diagnosed with Salmonella prostatitis among other comorbidities including heartworm infestation. Additionally, mitigation of zoonotic spread is emphasized as one of the owners was six months pregnant at the time of diagnosis.

Discussion

The pathogenesis of Salmonella prostatitis is unknown but explanations pertaining to enteric salmonellosis, such as the lifestyle and stress of living as a stray may have contributed and contamination from an enteric infection may have also been possible. Several recommendations were made to reduce the likelihood of zoonotic transmission including frequent hand washing, avoidance of the patient’s mouth, change in location of where the patient was fed, the use of an isolated area outside for urination and defecation, and the use of dilute bleach to clean areas soiled by the patient’s bodily fluids. Monitoring of the prostatic infection was facilitated with prostatic wash instead of urine culture. This decision was made as prostatic infections have been shown to intermittently shed bacteria into the urine, leading to possible false negative urine cultures and potential catastrophic zoonotic infection.

Severe Concomitant Physaloptera sp., Dirofilaria immitis, Toxocara cati, Dipylidium caninum, Ancylostoma sp. and Taenia taeniaeformis Infection in a Cat

Here we describe an unusual and severe mixed parasitic infection in a cat that died during routine surgery. Gastric Physaloptera sp., cardiac Dirofilaria immitis, and intestinal Toxocara cati, Dipylidium caninum, Ancylostoma sp. and Taenia taeniaeformis were observed. Histologic lesions included chronic proliferative pulmonary endarteritis, mild increase of mucosal intestinal white cells, and terminal aspiration of gastric content. The severe dirofilariasis may have contributed to this patient death during anesthesia.

The American Heartworm Society and Association of Shelter Veterinarians' 2019 Shelter Heartworm Management Practices Survey

The primary objective of the 2019 Shelter Heartworm Management Practices Survey was to identify the current practices employed for the prevention, diagnosis, and management of heartworm disease in animal shelters. Survey questions were developed to collect the information of interest for dogs, cats, and ferrets under the care of sheltering organizations along with demographic information about these organizations. An electronic survey was distributed to the American Heartworm Society and Association of Shelter Veterinarians' mailing lists in February-March 2019. Cross-posting of the survey on relevant lists was encouraged. The survey invitation was directed toward veterinarians delivering care in an animal shelter and excluded practitioners providing services for shelters, shelter animals, or recently adopted animals within a private practice setting. A total of 242 survey responses were received representing private humane societies/societies for the prevention of cruelty to animals (39.7%), municipal animal control facilities (24.9%), traditional (public-private partnership) shelters (21.7%), foster-based organizations (7.9%), sanctuaries (2.6%), and breed/species-specific rescues (2.1%). The largest proportion of respondent shelters were from the southeastern United States (36.9%) and over two-thirds of the shelters had full-time shelter veterinarians (69.0%). Most respondents provided monthly heartworm preventives for dogs (81.1%) and used oral ivermectin products per product labels (67.2%) to do so. Extralabel use of preventives was reported by 21.3% of respondents. Most respondents tested all dogs >6 months of age for heartworm infection (81.9%) and did so during the intake examination (56.6%) with antigen tests (92.2%). At least some heartworm positive dogs were treated by most respondents (93.1%) using a 3-dose (42.5%) or 2-dose (37.9%) melarsomine protocol. Non-arsenical treatment protocols were utilized by 16.8% of respondents. Protocols typically included adjunctive treatment with doxycycline or minocycline (92.3%), prednisone (71.3%), and macrocyclic lactones (58.6%). Nearly two-thirds of respondents housed dogs within foster homes after treatment (65.1%). Heartworm prevention was provided by 29.9% of respondents that admitted cats and 9.9% of those that admitted ferrets. These results can be used to identify challenges to meeting recommended practices regarding prevention, diagnosis, and treatment of heartworm disease in the animal shelter setting and to target operational and educational resources toward the areas of greatest need.